Stay updated on Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unchanged 403 error page. The site revision also advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T18:57:18.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:15:56.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating restricted access to the study record.
    Difference
    20%
    Check dated 2026-09-22T22:18:02.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.6 to v3.7.0, signaling a software/format update to the study details page. No changes are observed in the study content, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-09-15T21:40:14.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page metadata rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-09-01T18:17:23.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The study identifiers now include '2016 ( U.S. NIH Grant/Contract )', linking the record to NIH funding. This provides funding context for the study within NIH grant documentation.
    Difference
    0.0%
    Check dated 2026-08-25T19:36:33.000Z thumbnail image

Stay in the know with updates to Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enapotamab Vedotin Safety Study in Solid Tumors Clinical Trial page.